XML 54 R45.htm IDEA: XBRL DOCUMENT
v3.20.1

License Agreements - Additional Information (Details) - Novartis International Pharmaceutical Ltd. - USD ($) |  | 1 Months Ended | 12 Months Ended
--- | --- | --- | ---
Mar. 23, 2017 | May 31, 2019 | May 31, 2017 | Dec. 31, 2019
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |
License agreement termination description |  |  |  | The agreement may be terminated by either party upon a material breach by the other party that is not cured within 60 days after written notice. The Company may terminate the agreement in its entirety or on a product-by-product or country-by-country basis with or without cause with 60 days’ prior written notice.
Payment for development milestone |  | $ 2,500,000 | $ 300,000 |
Maximum |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |
Aggregate amount payable upon satisfaction of clinical milestones | $ 4,300,000 |  |  |
Aggregate amount payable upon satisfaction of regulatory milestones for first indication approved | 24,000,000 |  |  |
Aggregate amount payable upon satisfaction of regulatory milestones for second indication approved | 18,000,000 |  |  |
Aggregate amount payable upon satisfaction of commercial milestones | $ 125,000,000 |  |  |
License Agreement | Series A Preferred Stock |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |
Shares issued | 2,587,992 |  |  |
Fair value of license agreement | $ 3,200,000 |  |  |
Fair value of shares issued | $ 1.22 |  |  |

X
- Definition License agreement milestone payments upon satisfaction of clinical milestones payable. + References No definition available. + Details
Name: | torc_LicenseAgreementMilestonePaymentsUponSatisfactionOfClinicalMilestonesPayable
Namespace Prefix: | torc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition License agreement milestone payments upon satisfaction of commercial milestones payable. + References No definition available. + Details
Name: | torc_LicenseAgreementMilestonePaymentsUponSatisfactionOfCommercialMilestonesPayable
Namespace Prefix: | torc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition License agreement milestone payments upon satisfaction of regulatory milestones payable for first indication approved. + References No definition available. + Details
Name: | torc_LicenseAgreementMilestonePaymentsUponSatisfactionOfRegulatoryMilestonesPayableForFirstIndicationApproved
Namespace Prefix: | torc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition License agreement milestone payments upon satisfaction of regulatory milestones payable for second indication approved. + References No definition available. + Details
Name: | torc_LicenseAgreementMilestonePaymentsUponSatisfactionOfRegulatoryMilestonesPayableForSecondIndicationApproved
Namespace Prefix: | torc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition License agreement termination description. + References No definition available. + Details
Name: | torc_LicenseAgreementTerminationDescription
Namespace Prefix: | torc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash payments for development or clinical milestones achieved under the license agreements. + References No definition available. + Details
Name: | torc_LicenseAgreementsPaymentsForDevelopmentMilestones
Namespace Prefix: | torc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 + Details
Name: | us-gaap_SharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Value of new stock classified as temporary equity issued during the period. + References No definition available. + Details
Name: | us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=torc_NovartisInternationalPharmaceuticalLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=torc_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |